| Natural killer cell-produced IFN-γ and TNF-α induce target cell cytolysis through up-regulation of ICAM-1 R Wang, JJ Jaw, NC Stutzman, Z Zou, PD Sun Journal of leukocyte biology 91 (2), 299-309, 2012 | 344 | 2012 |
| Negative regulation of MDA5-but not RIG-I-mediated innate antiviral signaling by the dihydroxyacetone kinase F Diao, S Li, Y Tian, M Zhang, LG Xu, Y Zhang, RP Wang, D Chen, Z Zhai, ... Proceedings of the National Academy of Sciences 104 (28), 11706-11711, 2007 | 162 | 2007 |
| REUL is a novel E3 ubiquitin ligase and stimulator of retinoic-acid-inducible gene-I D Gao, YK Yang, RP Wang, X Zhou, FC Diao, MD Li, ZH Zhai, ZF Jiang, ... PloS one 4 (6), e5760, 2009 | 149 | 2009 |
| Negative feedback regulation of cellular antiviral signaling by RBCK1-mediated degradation of IRF3 M Zhang, Y Tian, RP Wang, D Gao, Y Zhang, FC Diao, DY Chen, ZH Zhai, ... Cell research 18 (11), 1096-1104, 2008 | 145 | 2008 |
| Recognition and functional activation of the human IgA receptor (FcαRI) by C-reactive protein J Lu, KD Marjon, LL Marnell, R Wang, C Mold, TW Du Clos, P Sun Proceedings of the National Academy of Sciences 108 (12), 4974, 2011 | 96 | 2011 |
| RBCK1 negatively regulates tumor necrosis factor-and interleukin-1-triggered NF-κB activation by targeting TAB2/3 for degradation Y Tian, Y Zhang, B Zhong, YY Wang, FC Diao, RP Wang, M Zhang, ... Journal of Biological Chemistry 282 (23), 16776-16782, 2007 | 79 | 2007 |
| Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-myosin II and TGF-β signaling C Zhang, HJ Lee, A Shrivastava, R Wang, TJ McQuiston, SS Challberg, ... Cell reports 25 (3), 598-610. e5, 2018 | 70 | 2018 |
| Differential regulation of IKKα-mediated activation of IRF3/7 by NIK RP Wang, M Zhang, Y Li, FC Diao, D Chen, Z Zhai, HB Shu Molecular immunology 45 (7), 1926-1934, 2008 | 44 | 2008 |
| The CXXC finger 5 protein is required for DNA damage-induced p53 activation M Zhang, RP Wang, YY Wang, FC Diao, F Lu, D Gao, DY Chen, ZH Zhai, ... Science in China Series C: Life Sciences 52 (6), 528-538, 2009 | 40 | 2009 |
| WDR34 is a novel TAK1-associated suppressor of the IL-1R/TLR3/TLR4-induced NF-κB activation pathway D Gao, R Wang, B Li, Y Yang, Z Zhai, DY Chen Cellular and molecular life sciences 66, 2573-2584, 2009 | 35 | 2009 |
| HIV-1 targets L-selectin for adhesion and induces its shedding for viral release J Kononchik, J Ireland, Z Zou, J Segura, G Holzapfel, A Chastain, R Wang, ... Nature Communications 9 (1), 2825, 2018 | 17 | 2018 |
| Natural killer cell-mediated shedding of ULBP2 R Wang, PD Sun PLoS One 9 (3), e91133, 2014 | 16 | 2014 |
| AIM Platform: a novel nano artificial antigen-presenting cell-based clinical system designed to consistently produce multi-antigen-specific T-cell products with potent and … L Suarez, R Wang, S Carmer, D Bednarik, H Myint, K Jones, M Oelke Transfusion Medicine and Hemotherapy 47 (6), 464-471, 2020 | 4 | 2020 |
| AIM™ platform: A new immunotherapy approach for viral diseases D Langan, R Wang, K Tidwell, S Mitiku, A Farrell, C Johnson, A Parks, ... Frontiers in Medicine 9, 1070529, 2022 | 1 | 2022 |
| High level stable expression of recombinant HIV gp120 in glutamine synthetase gene deficient HEK293T cells Z Zou, R Wang, EP Go, H Desaire, PD Sun Protein Expression and Purification 181, 105837, 2021 | 1 | 2021 |
| Over-expression of a human CD62L ecto-domain and a potential role of RNA pseudoknot structures in recombinant protein expression M Spencer, N Max, J Ireland, Z Zou, R Wang, P Sun Protein expression and purification 140, 65-73, 2017 | 1 | 2017 |
| Inhibition of HIV-1 release by ADAM metalloproteinase inhibitors J Ireland, J Segura, G Shi, J Buchwald, G Roth, TJ Shen, R Wang, X Ji, ... Frontiers in Microbiology 15, 1385775, 2024 | | 2024 |
| Ex Vivo Enriched Tumor Antigen-Specific T Cells Are Optimal Effectors of T Cell Engagers and Tumor-Specific T Cell Receptor/T Cell Engager Combination Provides Synergistic … M Bariana, M Batistick, M Oelke, S Kim, E Cassella, S Anand, S Anuncio, ... Blood 142, 2056, 2023 | | 2023 |
| 395 Enhancement of bispecific T cell engagers (bispecific TCE) killing potency in AML with the neximmune artificial immune modulation (AIM™) adoptive cell therapy (ACT) T cells R Wang, M Oelke, S Jain, S Kim, J Ragheb, A Parks, R Wang, C Reed, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| 396 Artificial Immune Modulation (AIM) nanoparticles expand antigen specific CD8 T cells from both naïve and memory T cell populations R Wang, L Suarez, B Hahn, A Farrell, S Kim, M Oelke Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
Feici DiaoNIMHVerified email at mail.nih.gov
